Navigating Ocular Toxicity During Cancer Treatment

Did you know that up to 30% of patients undergoing cancer treatment experience ocular side effects? These effects can range from mild discomfort to severe vision changes. Understanding ocular toxicity, its causes, and how to manage it is crucial for maintaining eye health during cancer therapy.

Specific Cancer Drugs and Their Ocular Side Effects

Certain cancer drugs are notorious for causing ocular toxicity. Here's a breakdown of some common culprits:

• Tamoxifen: Known to cause tamoxifen retinopathy, which can lead to changes in the retina.
• Checkpoint Inhibitors (e.g., Pembrolizumab): Can cause uveitis, an inflammation of the eye's middle layer.
• Taxanes (e.g., Paclitaxel): Often lead to epiphora, or excessive tearing.

These side effects typically emerge within the first few weeks of treatment, but vigilance is required throughout the therapy course.

Urgent vs. Expected Symptoms

Recognizing symptoms early can prevent severe complications. Here's what to watch for:

• Urgent Symptoms: Sudden vision loss, severe eye pain, or intense redness warrant immediate medical attention.
• Expected Symptoms: Mild dryness, slight irritation, or temporary blurred vision are common but should be monitored.

The Importance of Baseline Eye Exams

Before starting treatment with drugs known for ocular side effects, a baseline eye exam is essential. This exam helps:

• Establish a reference point for eye health.
• Detect pre-existing conditions that could be exacerbated by treatment.
• Facilitate timely intervention if changes occur.

Co-management with Oncology and Ophthalmology

Collaboration between oncologists and ophthalmologists is key. Oncology-ophthalmology co-management guidelines recommend:

• Regular eye exams throughout treatment.
• Immediate reporting of any new or worsening symptoms.
• Adjustments to cancer therapy if severe ocular toxicity develops.

Conclusion

Ocular toxicity is a significant concern during cancer treatment, but proactive management can mitigate risks. Knowing which drugs to watch for and understanding the symptoms can empower patients to maintain their vision. Regular consultations with your eye care professional, combined with a collaborative approach between your oncology and ophthalmology teams, can make all the difference.

If you're undergoing cancer treatment and have concerns about your eye health, schedule a consultation with your eye care professional today. They can provide tailored advice and support to help you navigate this challenging time.